{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:14:58Z","timestamp":1792818898754,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1053\/j.seminoncol.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T09:30:35Z","timestamp":1249464635000},"page":"S35-S45","source":"Crossref","is-referenced-by-count":191,"special_numbering":"S2","title":["Diagnostic Tools for Neoplastic Meningitis: Detecting Disease, Identifying Patient Risk, and Determining Benefit of Treatment"],"prefix":"10.1053","volume":"36","author":[{"given":"Marc C.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris D.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2009.05.005_bib1","first-page":"143","article-title":"Leptomeningeal metastases","volume":"vol 45","author":"Posner","year":"1995"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.nrl.0000219732.33321.cc","article-title":"Neoplastic meningitis","volume":"12","author":"Chamberlain","year":"2006","journal-title":"Neurologist"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/0-387-24199-X_2","article-title":"Leptomeningeal neoplasia: epidemiology, clinical presentation, CSF analysis and diagnostic imaging","volume":"125","author":"Enting","year":"2005","journal-title":"Cancer Treat Res"},{"issue":"Suppl","key":"10.1053\/j.seminoncol.2009.05.005_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1586\/14737175.4.4.S3","article-title":"Defining patients at risk for neoplastic meningitis: what parameters can be used to determine who should be treated?","volume":"4","author":"Chamberlain","year":"2004","journal-title":"Expert Rev Neurother"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3171\/foc.1998.4.6.7","article-title":"Diagnosis and outcome measures in trials for neoplastic meningitis: a review of the literature and clinical experience","volume":"4","author":"Glantz","year":"1998","journal-title":"Neurosurg Focus"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","article-title":"Carcinomatous meningitis secondary to non-small cell lung cancer: combined modality therapy","volume":"55","author":"Chamberlain","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archneur.1997.00550230037013","article-title":"Prognostic significance of co-existent bulky metastatic central nervous system disease in patients with leptomeningeal metastases","volume":"54","author":"Chamberlain","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib9","first-page":"1010","article-title":"Prognostic factors and outcomes in patients with leptomeningeal melanomatosis","volume":"10","author":"Harstad","year":"2008","journal-title":"Neurooncology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib10","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.46.6.1674","article-title":"Prognostic significance of 111 indium-DTPA CSF flow studies","volume":"46","author":"Chamberlain","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.WNL.0000145599.06491.71","article-title":"Neoplastic meningitis-related encephalopathy: prognostic significance","volume":"63","author":"Chamberlain","year":"2005","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archneurol.2008.506","article-title":"Neoplastic meningitis: prognostic significance of Karnofsky performance status","volume":"66","author":"Chamberlain","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","article-title":"Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib14","first-page":"42","article-title":"A comparison between ventricular and lumbar CSF cytology in adult patients with leptomeningeal metastases","volume":"3","author":"Chamberlain","year":"2001","journal-title":"Neurooncology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.40.3_Part_1.435","article-title":"Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain","volume":"40","author":"Chamberlain","year":"1990","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2141.2004.04853.x","article-title":"Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis\u2014a single centre experience","volume":"124","author":"Zeiser","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1097-0339(200012)23:6<369::AID-DC1>3.0.CO;2-3","article-title":"Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis","volume":"23","author":"French","year":"2000","journal-title":"Diagn Cytopathol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","article-title":"CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies","volume":"68","author":"Bromberg","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib22","author":"Brem"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","article-title":"A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis","volume":"77","author":"Rhodes","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/WNL.58.3.390","article-title":"CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes","volume":"58","author":"Gleissner","year":"2002","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.50.4.1173","article-title":"Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers","volume":"50","author":"Chamberlain","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00149379","article-title":"Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors","volume":"7","author":"Twijnstra","year":"1989","journal-title":"J Neurooncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.surneu.2004.06.011","article-title":"Intrathecal chemotherapy for patients with meningeal carcinomatosis","volume":"63","author":"Yoshida","year":"2005","journal-title":"Surg Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-003-0082-y","article-title":"The pathogenesis of neoplastic meningitis","volume":"5","author":"Groves","year":"2003","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00415-006-0187-y","article-title":"CSF protein profiling using Multiplex Immuno-assay: a potential new diagnostic tool for leptomeningeal metastases","volume":"253","author":"Brandsma","year":"2006","journal-title":"J Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.wnl.0000223348.42106.97","article-title":"CSF levels of growth factors and plasminogen activators in leptomeningeal metastases","volume":"67","author":"van de Langerijt","year":"2006","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib32","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/01.wnl.0000178981.39984.c2","article-title":"CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases","volume":"65","author":"Reijneveld","year":"2005","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO;2-2","article-title":"Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis","volume":"82","author":"Friedberg","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6601953","article-title":"Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value","volume":"91","author":"Herrlinger","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib35","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.54.8.1670","article-title":"Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis","volume":"54","author":"Stockhammer","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-8981(03)00023-8","article-title":"Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis","volume":"329","author":"Nagai","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2007.12.1053","article-title":"Protein biomarker identification in the CSF of patients with CNS lymphoma","volume":"26","author":"Roy","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","article-title":"Leptomeningeal metastasis: Indium-DTPA CSF flow studies","volume":"41","author":"Chamberlain","year":"1991","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/01.wnl.0000226829.35122.32","article-title":"CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases","volume":"66","author":"Groves","year":"2006","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib40","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2002.07.500","article-title":"Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points","volume":"20","author":"Mehta","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib41","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2003.12.122","article-title":"Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases","volume":"21","author":"Mehta","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","article-title":"Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial","volume":"22","author":"Meyers","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.24210","article-title":"Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology","volume":"115","author":"Chamberlain","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","article-title":"Neoplastic meningitis","volume":"13","author":"Chamberlain","year":"2008","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib45","first-page":"208","article-title":"A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies","volume":"10","author":"Groves","year":"2008","journal-title":"Neurooncology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib46","first-page":"505","article-title":"Leptomeningeal metastases due to melanoma: combined modality therapy","volume":"9","author":"Chamberlain","year":"1996","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib47","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.49.6.1728","article-title":"Non-AIDS related lymphomatous meningitis: combined modality therapy","volume":"49","author":"Chamberlain","year":"1997","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005803918194","article-title":"Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy","volume":"35","author":"Chamberlain","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib49","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1200\/JCO.2006.07.0250","article-title":"Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer","volume":"24","author":"Gabos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.breast.2008.04.006","article-title":"HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients","volume":"17","author":"Wolstenholme","year":"2008","journal-title":"Breast"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib51","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","article-title":"Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first line treatment","volume":"23","author":"Marty","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jnci\/djn216","article-title":"Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain","volume":"100","author":"Gril","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib53","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ncponc1243","article-title":"New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer","volume":"6","author":"Melisko","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-008-9594-5","article-title":"Risk of neoplastic meningitis following surgical resection of cerebellar metastases","volume":"89","author":"Chamberlain","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1053\/j.seminoncol.2009.05.005_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/JNS\/2008\/108\/2\/0248","article-title":"Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa","volume":"108","author":"Suki","year":"2008","journal-title":"J Neurosurg"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775409000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775409000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T05:40:45Z","timestamp":1590039645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775409000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":56,"alternative-id":["S0093775409000955"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2009.05.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}